Anti-Cd20 Immunotherapy as a Bridge to Tolerance, After Allogeneic Stem Cell Transplantation for Patients With Chronic Lymphocytic Leukaemia: Results of the CLLX4 Trial
British Journal of Haematology - United Kingdom
doi 10.1111/bjh.15181
Full Text
Open PDFAbstract
Available in full text
Categories
Date
March 12, 2018
Authors
Publisher
Wiley